Literature DB >> 17290096

Long-term outcome of Guillain-Barré syndrome.

S Koeppen1, K Kraywinkel, T E Wessendorf, C E Ehrenfeld, M Schürks, H C Diener, C Weimar.   

Abstract

OBJECTIVES: To investigate long-term neurological residua after Guillain-Barré syndrome (GBS) and to evaluate the predictive value of respiratory insufficiency during the acute stage of the disease.
METHODS: Thirty-four patients with GBS including 5 patients with Miller-Fisher syndrome admitted to a university hospital between 1994 and 2002 underwent a neurological and electrophysiological follow-up examination 7 - 86 months after onset of GBS.
RESULTS: Of the 34 patients, 5 patients had completely recovered, 11 patients demonstrated mild residual symptoms and/or signs, and 18 patients presented with functionally relevant neurological deficits predominantly in the lower extremity, although all patients could walk without assistance and none showed respiratory failure. Nerve conduction studies revealed abnormal findings in 30 patients. Autonomic function testing of the cardiovascular system showed a pathological blood pressure response to standing in 27 of 33 patients. No association was found between the course of the disease and sleep-disordered breathing at follow-up. Age at onset, need for mechanical ventilation, and duration of the plateau phase correlated with severity of neurological residua at follow-up.
CONCLUSIONS: There was a high persistence of residual sensorimotor signs and symptoms after GBS in our cohort. In addition, abnormal blood pressure declines not associated with clinically overt orthostatic dysregulation were detected in the majority of our patients at follow-up. This is in contrast to previous reports describing a gradual improvement of autonomic dysfunction after 2 - 18 months. A combined prognostic score based on patient age, duration of the plateau phase, and ventilatory failure in the acute stage of GBS might predict the long-term outcome.

Entities:  

Mesh:

Year:  2006        PMID: 17290096     DOI: 10.1385/NCC:5:3:235

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  45 in total

1.  Detection of serious bradyarrhythmias in Guillain-Barré syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum.

Authors:  P Flachenecker; K Lem; W Müllges; K Reiners
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

2.  [Outcome after Guillain-Barré syndrome: comparison of motor function status and changes in social life].

Authors:  Takahide Nagashima; Yukihiro Nishimoto; Koichi Hirata; Nobuhiro Yuki
Journal:  Rinsho Shinkeigaku       Date:  2004-01

3.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors:  J B Winer; R A Hughes; C Osmond
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

4.  Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands.

Authors:  R Van Koningsveld; P A Van Doorn; P I Schmitz; C W Ang; F G Van der Meché
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

5.  Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study.

Authors:  P Flachenecker; H P Hartung; K Reiners
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

6.  Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group.

Authors:  L H Visser; P I Schmitz; J Meulstee; P A van Doorn; F G van der Meché
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

7.  How Guillain-Barre patients experience their functioning after 1 year.

Authors:  Robert A J A M Bernsen; Aeiko E J de Jager; Frans G A van der Meché; Theo P B M Suurmeijer
Journal:  Acta Neurol Scand       Date:  2005-07       Impact factor: 3.209

Review 8.  Corticosteroids for treating Guillain-Barré syndrome.

Authors:  R A Hughes; F G van der Meché
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 9.  Intensive management and treatment of severe Guillain-Barré syndrome.

Authors:  E F Hund; C O Borel; D R Cornblath; D F Hanley; G M McKhann
Journal:  Crit Care Med       Date:  1993-03       Impact factor: 7.598

10.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  10 in total

1.  Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome.

Authors:  F Khan; J F Pallant; L Ng; A Bhasker
Journal:  J Neurol       Date:  2010-07-13       Impact factor: 4.849

2.  Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation.

Authors:  J Witsch; N Galldiks; A Bender; R Kollmar; J Bösel; C Hobohm; A Günther; I Schirotzek; K Fuchs; E Jüttler
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

3.  [Sepsis-associated Guillain-Barré syndrome].

Authors:  S Rehberg; H Freise; P Young; C Ertmer; B Ellger; H Van Aken; M Westphal
Journal:  Anaesthesist       Date:  2009-02       Impact factor: 1.041

4.  The effect of secular trends and specialist neurocritical care on mortality for patients with intracerebral haemorrhage, myasthenia gravis and Guillain-Barré syndrome admitted to critical care : an analysis of the Intensive Care National Audit & Research Centre (ICNARC) national United Kingdom database.

Authors:  Maxwell S Damian; Yoav Ben-Shlomo; Robin Howard; Tony Bellotti; David Harrison; Kathryn Griggs; Kathryn Rowan
Journal:  Intensive Care Med       Date:  2013-05-24       Impact factor: 17.440

Review 5.  Autonomic involvement in Guillain-Barré syndrome: an update.

Authors:  Zoya Zaeem; Zaeem A Siddiqi; Douglas W Zochodne
Journal:  Clin Auton Res       Date:  2018-07-17       Impact factor: 4.435

Review 6.  Guillain-Barré syndrome and variants.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-02-19       Impact factor: 3.806

7.  Mortality in mechanically ventilated patients of Guillain Barré Syndrome.

Authors:  Archana B Netto; Arun B Taly; Girish Baburao Kulkarni; Umamaheswara G S Rao; Shivaji Rao
Journal:  Ann Indian Acad Neurol       Date:  2011-10       Impact factor: 1.383

8.  Autonomic and peripheral nervous system function in acute tick-borne encephalitis.

Authors:  Bernhard Neumann; Wilhelm Schulte-Mattler; Sophie Brix; Peter Pöschl; Wolfgang Jilg; Ulrich Bogdahn; Andreas Steinbrecher; Ingo Kleiter
Journal:  Brain Behav       Date:  2016-05-05       Impact factor: 2.708

9.  Patient-reported symptoms and experience following Guillain-Barré syndrome and related conditions: Questionnaire development and validation.

Authors:  Aloysius Niroshan Siriwardena; Joseph N A Akanuwe; Vanessa Botan; Despina Laparidou; Ffion Curtis; Jennifer Jackson; Zahid B Asghar; Timothy L Hodgson
Journal:  Health Expect       Date:  2021-10-01       Impact factor: 3.377

10.  Patients' attitude towards vaccination after Guillain Barré syndrome.

Authors:  Ben-Ole Holtz; Alexander Grimm; Hubertus Axer
Journal:  Health Sci Rep       Date:  2021-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.